Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Autologous Biologics Market Research Report 2026
Global Autologous Biologics Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 115 Pages
Report ld: 6467463
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Autologous Biologics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Autologous Biologics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Autologous Biologics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Autologous Biologics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Autologous Biologics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Autologous Biologics. The Autologous Biologics market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Autologous Biologics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Autologous Biologics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Vericel Corporation
- BioTime, Inc.
- Pharmicell Co.
- BrainStorm Cell Therapeutics
- Opexa Therapeutics, Inc
- Pharmicell Co., Inc
- Neostem
- Dendreon Corporation
- Regenexx
- Cytori Therapeutics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Adipose Tissue
- Plasma
- Others
Segment by Application
- Hospitals
- Ambulatory Centers
- Research Centers
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Autologous Biologics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Autologous Biologics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Autologous Biologics Market Overview
1.1 Product Definition
1.2 Autologous Biologics by Type
1.2.1 Global Autologous Biologics Market Value by Type: 2025 vs 2032
1.2.2 Adipose Tissue
1.2.3 Plasma
1.2.4 Others
1.3 Autologous Biologics by Application
1.3.1 Global Autologous Biologics Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Ambulatory Centers
1.3.4 Research Centers
1.4 Global Autologous Biologics Market Size Estimates and Forecasts
1.4.1 Global Autologous Biologics Revenue 2021–2032
1.4.2 Global Autologous Biologics Sales 2021–2032
1.4.3 Global Autologous Biologics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Autologous Biologics Market Competition by Manufacturers
2.1 Global Autologous Biologics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Autologous Biologics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Autologous Biologics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Autologous Biologics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Autologous Biologics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Autologous Biologics, Product Types and Applications
2.7 Global Key Manufacturers of Autologous Biologics, Date of Entry into the Industry
2.8 Global Autologous Biologics Market Competitive Situation and Trends
2.8.1 Global Autologous Biologics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Autologous Biologics Players Market Share by Revenue
2.8.3 Global Autologous Biologics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Autologous Biologics Market Scenario by Region
3.1 Global Autologous Biologics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Autologous Biologics Sales by Region: 2021–2032
3.2.1 Global Autologous Biologics Sales by Region: 2021–2026
3.2.2 Global Autologous Biologics Sales by Region: 2027–2032
3.3 Global Autologous Biologics Revenue by Region: 2021–2032
3.3.1 Global Autologous Biologics Revenue by Region: 2021–2026
3.3.2 Global Autologous Biologics Revenue by Region: 2027–2032
3.4 North America Autologous Biologics Market Facts & Figures by Country
3.4.1 North America Autologous Biologics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Autologous Biologics Sales by Country (2021–2032)
3.4.3 North America Autologous Biologics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autologous Biologics Market Facts & Figures by Country
3.5.1 Europe Autologous Biologics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Autologous Biologics Sales by Country (2021–2032)
3.5.3 Europe Autologous Biologics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autologous Biologics Market Facts & Figures by Region
3.6.1 Asia Pacific Autologous Biologics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Autologous Biologics Sales by Region (2021–2032)
3.6.3 Asia Pacific Autologous Biologics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Autologous Biologics Market Facts & Figures by Country
3.7.1 Latin America Autologous Biologics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Autologous Biologics Sales by Country (2021–2032)
3.7.3 Latin America Autologous Biologics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autologous Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Autologous Biologics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Autologous Biologics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Autologous Biologics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autologous Biologics Sales by Type (2021–2032)
4.1.1 Global Autologous Biologics Sales by Type (2021–2026)
4.1.2 Global Autologous Biologics Sales by Type (2027–2032)
4.1.3 Global Autologous Biologics Sales Market Share by Type (2021–2032)
4.2 Global Autologous Biologics Revenue by Type (2021–2032)
4.2.1 Global Autologous Biologics Revenue by Type (2021–2026)
4.2.2 Global Autologous Biologics Revenue by Type (2027–2032)
4.2.3 Global Autologous Biologics Revenue Market Share by Type (2021–2032)
4.3 Global Autologous Biologics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Autologous Biologics Sales by Application (2021–2032)
5.1.1 Global Autologous Biologics Sales by Application (2021–2026)
5.1.2 Global Autologous Biologics Sales by Application (2027–2032)
5.1.3 Global Autologous Biologics Sales Market Share by Application (2021–2032)
5.2 Global Autologous Biologics Revenue by Application (2021–2032)
5.2.1 Global Autologous Biologics Revenue by Application (2021–2026)
5.2.2 Global Autologous Biologics Revenue by Application (2027–2032)
5.2.3 Global Autologous Biologics Revenue Market Share by Application (2021–2032)
5.3 Global Autologous Biologics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Vericel Corporation
6.1.1 Vericel Corporation Company Information
6.1.2 Vericel Corporation Description and Business Overview
6.1.3 Vericel Corporation Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Vericel Corporation Autologous Biologics Product Portfolio
6.1.5 Vericel Corporation Recent Developments/Updates
6.2 BioTime, Inc.
6.2.1 BioTime, Inc. Company Information
6.2.2 BioTime, Inc. Description and Business Overview
6.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 BioTime, Inc. Autologous Biologics Product Portfolio
6.2.5 BioTime, Inc. Recent Developments/Updates
6.3 Pharmicell Co.
6.3.1 Pharmicell Co. Company Information
6.3.2 Pharmicell Co. Description and Business Overview
6.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pharmicell Co. Autologous Biologics Product Portfolio
6.3.5 Pharmicell Co. Recent Developments/Updates
6.4 BrainStorm Cell Therapeutics
6.4.1 BrainStorm Cell Therapeutics Company Information
6.4.2 BrainStorm Cell Therapeutics Description and Business Overview
6.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolio
6.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates
6.5 Opexa Therapeutics, Inc
6.5.1 Opexa Therapeutics, Inc Company Information
6.5.2 Opexa Therapeutics, Inc Description and Business Overview
6.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Portfolio
6.5.5 Opexa Therapeutics, Inc Recent Developments/Updates
6.6 Pharmicell Co., Inc
6.6.1 Pharmicell Co., Inc Company Information
6.6.2 Pharmicell Co., Inc Description and Business Overview
6.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Pharmicell Co., Inc Autologous Biologics Product Portfolio
6.6.5 Pharmicell Co., Inc Recent Developments/Updates
6.7 Neostem
6.7.1 Neostem Company Information
6.7.2 Neostem Description and Business Overview
6.7.3 Neostem Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Neostem Autologous Biologics Product Portfolio
6.7.5 Neostem Recent Developments/Updates
6.8 Dendreon Corporation
6.8.1 Dendreon Corporation Company Information
6.8.2 Dendreon Corporation Description and Business Overview
6.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dendreon Corporation Autologous Biologics Product Portfolio
6.8.5 Dendreon Corporation Recent Developments/Updates
6.9 Regenexx
6.9.1 Regenexx Company Information
6.9.2 Regenexx Description and Business Overview
6.9.3 Regenexx Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Regenexx Autologous Biologics Product Portfolio
6.9.5 Regenexx Recent Developments/Updates
6.10 Cytori Therapeutics
6.10.1 Cytori Therapeutics Company Information
6.10.2 Cytori Therapeutics Description and Business Overview
6.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cytori Therapeutics Autologous Biologics Product Portfolio
6.10.5 Cytori Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autologous Biologics Industry Chain Analysis
7.2 Autologous Biologics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autologous Biologics Production Mode & Process Analysis
7.4 Autologous Biologics Sales and Marketing
7.4.1 Autologous Biologics Sales Channels
7.4.2 Autologous Biologics Distributors
7.5 Autologous Biologics Customer Analysis
8 Autologous Biologics Market Dynamics
8.1 Autologous Biologics Industry Trends
8.2 Autologous Biologics Market Drivers
8.3 Autologous Biologics Market Challenges
8.4 Autologous Biologics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Autologous Biologics Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Autologous Biologics Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Autologous Biologics Market Competitive Situation by Manufacturers in 2025
Table 4. Global Autologous Biologics Sales (Kg) of Key Manufacturers (2021–2026)
Table 5. Global Autologous Biologics Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Autologous Biologics Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Autologous Biologics Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Autologous Biologics Average Price (US$/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Autologous Biologics, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Autologous Biologics, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Autologous Biologics, Product Types and Applications
Table 12. Global Key Manufacturers of Autologous Biologics, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autologous Biologics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Autologous Biologics Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Biologics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Autologous Biologics Sales by Region (Kg), 2021–2026
Table 18. Global Autologous Biologics Sales Market Share by Region (2021–2026)
Table 19. Global Autologous Biologics Sales by Region (Kg), 2027–2032
Table 20. Global Autologous Biologics Sales Market Share by Region (2027–2032)
Table 21. Global Autologous Biologics Revenue by Region (US$ Million), 2021–2026
Table 22. Global Autologous Biologics Revenue Market Share by Region (2021–2026)
Table 23. Global Autologous Biologics Revenue by Region (US$ Million), 2027–2032
Table 24. Global Autologous Biologics Revenue Market Share by Region (2027–2032)
Table 25. North America Autologous Biologics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Autologous Biologics Sales by Country (Kg), 2021–2026
Table 27. North America Autologous Biologics Sales by Country (Kg), 2027–2032
Table 28. North America Autologous Biologics Revenue by Country (US$ Million), 2021–2026
Table 29. North America Autologous Biologics Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Autologous Biologics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Autologous Biologics Sales by Country (Kg), 2021–2026
Table 32. Europe Autologous Biologics Sales by Country (Kg), 2027–2032
Table 33. Europe Autologous Biologics Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Autologous Biologics Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Autologous Biologics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Autologous Biologics Sales by Region (Kg), 2021–2026
Table 37. Asia Pacific Autologous Biologics Sales by Region (Kg), 2027–2032
Table 38. Asia Pacific Autologous Biologics Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Autologous Biologics Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Autologous Biologics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Autologous Biologics Sales by Country (Kg), 2021–2026
Table 42. Latin America Autologous Biologics Sales by Country (Kg), 2027–2032
Table 43. Latin America Autologous Biologics Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Autologous Biologics Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Autologous Biologics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Autologous Biologics Sales by Country (Kg), 2021–2026
Table 47. Middle East and Africa Autologous Biologics Sales by Country (Kg), 2027–2032
Table 48. Middle East and Africa Autologous Biologics Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Autologous Biologics Revenue by Country (US$ Million), 2027–2032
Table 50. Global Autologous Biologics Sales (Kg) by Type (2021–2026)
Table 51. Global Autologous Biologics Sales (Kg) by Type (2027–2032)
Table 52. Global Autologous Biologics Sales Market Share by Type (2021–2026)
Table 53. Global Autologous Biologics Sales Market Share by Type (2027–2032)
Table 54. Global Autologous Biologics Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Autologous Biologics Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Autologous Biologics Revenue Market Share by Type (2021–2026)
Table 57. Global Autologous Biologics Revenue Market Share by Type (2027–2032)
Table 58. Global Autologous Biologics Price (US$/Kg) by Type (2021–2026)
Table 59. Global Autologous Biologics Price (US$/Kg) by Type (2027–2032)
Table 60. Global Autologous Biologics Sales (Kg) by Application (2021–2026)
Table 61. Global Autologous Biologics Sales (Kg) by Application (2027–2032)
Table 62. Global Autologous Biologics Sales Market Share by Application (2021–2026)
Table 63. Global Autologous Biologics Sales Market Share by Application (2027–2032)
Table 64. Global Autologous Biologics Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Autologous Biologics Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Autologous Biologics Revenue Market Share by Application (2021–2026)
Table 67. Global Autologous Biologics Revenue Market Share by Application (2027–2032)
Table 68. Global Autologous Biologics Price (US$/Kg) by Application (2021–2026)
Table 69. Global Autologous Biologics Price (US$/Kg) by Application (2027–2032)
Table 70. Vericel Corporation Company Information
Table 71. Vericel Corporation Description and Business Overview
Table 72. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 73. Vericel Corporation Autologous Biologics Product
Table 74. Vericel Corporation Recent Developments/Updates
Table 75. BioTime, Inc. Company Information
Table 76. BioTime, Inc. Description and Business Overview
Table 77. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 78. BioTime, Inc. Autologous Biologics Product
Table 79. BioTime, Inc. Recent Developments/Updates
Table 80. Pharmicell Co. Company Information
Table 81. Pharmicell Co. Description and Business Overview
Table 82. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 83. Pharmicell Co. Autologous Biologics Product
Table 84. Pharmicell Co. Recent Developments/Updates
Table 85. BrainStorm Cell Therapeutics Company Information
Table 86. BrainStorm Cell Therapeutics Description and Business Overview
Table 87. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 88. BrainStorm Cell Therapeutics Autologous Biologics Product
Table 89. BrainStorm Cell Therapeutics Recent Developments/Updates
Table 90. Opexa Therapeutics, Inc Company Information
Table 91. Opexa Therapeutics, Inc Description and Business Overview
Table 92. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 93. Opexa Therapeutics, Inc Autologous Biologics Product
Table 94. Opexa Therapeutics, Inc Recent Developments/Updates
Table 95. Pharmicell Co., Inc Company Information
Table 96. Pharmicell Co., Inc Description and Business Overview
Table 97. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 98. Pharmicell Co., Inc Autologous Biologics Product
Table 99. Pharmicell Co., Inc Recent Developments/Updates
Table 100. Neostem Company Information
Table 101. Neostem Description and Business Overview
Table 102. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 103. Neostem Autologous Biologics Product
Table 104. Neostem Recent Developments/Updates
Table 105. Dendreon Corporation Company Information
Table 106. Dendreon Corporation Description and Business Overview
Table 107. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 108. Dendreon Corporation Autologous Biologics Product
Table 109. Dendreon Corporation Recent Developments/Updates
Table 110. Regenexx Company Information
Table 111. Regenexx Description and Business Overview
Table 112. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 113. Regenexx Autologous Biologics Product
Table 114. Regenexx Recent Developments/Updates
Table 115. Cytori Therapeutics Company Information
Table 116. Cytori Therapeutics Description and Business Overview
Table 117. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 118. Cytori Therapeutics Autologous Biologics Product
Table 119. Cytori Therapeutics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Autologous Biologics Distributors List
Table 123. Autologous Biologics Customers List
Table 124. Autologous Biologics Market Trends
Table 125. Autologous Biologics Market Drivers
Table 126. Autologous Biologics Market Challenges
Table 127. Autologous Biologics Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Autologous Biologics
Figure 2. Global Autologous Biologics Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Autologous Biologics Market Share by Type: 2025 & 2032
Figure 4. Adipose Tissue Product Picture
Figure 5. Plasma Product Picture
Figure 6. Others Product Picture
Figure 7. Global Autologous Biologics Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Autologous Biologics Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Ambulatory Centers
Figure 11. Research Centers
Figure 12. Global Autologous Biologics Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Autologous Biologics Market Size (US$ Million), 2021–2032
Figure 14. Global Autologous Biologics Sales (Kg), 2021–2032
Figure 15. Global Autologous Biologics Average Price (US$/Kg), 2021–2032
Figure 16. Autologous Biologics Report Years Considered
Figure 17. Autologous Biologics Sales Share by Manufacturers in 2025
Figure 18. Global Autologous Biologics Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Autologous Biologics Players: Market Share by Revenue in Autologous Biologics in 2025
Figure 20. Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Autologous Biologics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Autologous Biologics Sales Market Share by Country (2021–2032)
Figure 23. North America Autologous Biologics Revenue Market Share by Country (2021–2032)
Figure 24. United States Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Autologous Biologics Sales Market Share by Country (2021–2032)
Figure 27. Europe Autologous Biologics Revenue Market Share by Country (2021–2032)
Figure 28. Germany Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Autologous Biologics Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Autologous Biologics Revenue Market Share by Region (2021–2032)
Figure 35. China Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Autologous Biologics Sales Market Share by Country (2021–2032)
Figure 45. Latin America Autologous Biologics Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Autologous Biologics Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Autologous Biologics Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Autologous Biologics Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Autologous Biologics by Type (2021–2032)
Figure 55. Global Revenue Market Share of Autologous Biologics by Type (2021–2032)
Figure 56. Global Autologous Biologics Price (US$/Kg) by Type (2021–2032)
Figure 57. Global Sales Market Share of Autologous Biologics by Application (2021–2032)
Figure 58. Global Revenue Market Share of Autologous Biologics by Application (2021–2032)
Figure 59. Global Autologous Biologics Price (US$/Kg) by Application (2021–2032)
Figure 60. Autologous Biologics Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Autologous Biologics market?
The top companies in the global Autologous Biologics market are Vericel Corporation、BioTime, Inc.、Pharmicell Co..
Related Reports
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 78
USD 4250.00
(Single User License)
Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 131
USD 4900.00
(Single User License)
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Autologous Biologics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)
Global Autologous Biologics Market Research Report 2025
The global market for Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 78
USD 4250.00 (Single User License)Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 131
USD 4900.00 (Single User License)Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Autologous Biologics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)Global Autologous Biologics Market Research Report 2025
The global market for Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now